3rd Scientific Summit on Tobacco Harm Reduction: Novel products, Research & Policy
The Department of Biochemistry-Biotechnology, Postgraduate Program “Toxicology” of the University of Thessaly, and the Laboratory of Molecular Biology and Immunology, Department of Pharmacy of the University of Patras organized for the third consecutive year, the Scientific Summit on Tobacco Harm Reduction - Novel products, Research & Policy, in collaboration with the Department of Public & Community Health, University of West Attica, Athens, and the 2nd Cardiology Dept., University Hospital Attikon, Medical School, National and Kapodistrian University of Athens.
The COVID-19 pandemic and the high risk of a second wave contributed to their decision the 3rd Scientific Summit on Tobacco Harm Reduction to become virtual.
The organizers aim to attract top researchers, clinicians, and scientists from diverse fields, from around the world, to contribute to the 3rd Scientific Summit on Tobacco Harm Reduction. The frequency of alternative tobacco product use (e-cigarettes, Heat-not-Burn products, loose leaf, snus, etc.) among smokers and the association with switch and quit attempts is increasing; the scientific community is debating, in the attempt to explain the benefits and the risks associated with these products. Health issues are emerging that demand more research and sound interpretation of research and clinical data.
You can watch our scientists' presentations at the links below:
A proposed approach for evaluating harm reduction in adult smokers after switching from cigarettes to tobacco heating system (THS): biomarkers of potential harm
-- Dr. Christelle Haziza
Toxicological assessment of flavored e-liquids in Sprague Dawley rats in an OECD subchronic inhalation study complemented by systems toxicology endpoints
-- Dr. Davide Sciuscio
Systems toxicology assessment of a representative e-liquid formulation by using human primary bronchial epithelial cells
-- Dr. Diego Marescotti
Tobacco Heating System 2.2 in mild to moderate chronic obstructive pulmonary disease subjects: an exploratory analysis
-- Dr. Fancesco Sergio
IQOS uptake and history of tobacco product use: findings from cross-sectional surveys in Japan, Italy, and Germany
-- Steve Roulet